Join
Live feed
·
PRReleasevia Quantisnow
MeiraGTx Holdings plc logo

Graviton BioScience Corporation Announces Publication of Positive Ph1b Trial Results for GV101 (TDI01) in Chronic Graft versus Host Disease in Signal Transduction and Targeted Therapy, by Beijing Tide Pharmaceutical

ByQuantisnow·Wall Street's wire, on your screen.
MGTX· MeiraGTx Holdings plc
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track MGTX (MeiraGTx Holdings plc) and more on Quantisnow.